Results 191 to 200 of about 3,065,508 (250)

Diagnostic and therapeutic potential of carbon nanodots for ocular disease. [PDF]

Nanomedicine (Lond)
Mohapatra D, Corson TW.
europepmc   +1 more source

Intra-arterial chemotherapy for retinoblastoma: a structured narrative review. [PDF]

World J Pediatr Surg
Ren YH, Kang D, Shi C, Sun W.
europepmc   +1 more source

Hydroxysafflor Yellow A for Diabetic Retinopathy: A Critical Review of Retinal Neurovascular Mechanisms and Systemic-to-Ocular Pharmacokinetic Barriers. [PDF]

Antioxidants (Basel)
Liu J, Liu W, Li L, Zhang Q, Zhang J, Yan W.   +5 more
europepmc   +1 more source

Meibomian Gland-Mediated Drug Delivery via Eyelid Application of Troxipide Nanoparticles Improves an N-Acetylcysteine-Induced Dry Eye. [PDF]

Pharmaceutics
Otake H, Tanaka R, Ogata F, Misra M, Kanai K, Tsubaki M, Yamamoto N, Kawasaki N, Nagai N.   +8 more
europepmc   +1 more source

Water-Free Cyclosporine 0.1% in Dry Eye Disease: Formulation Rationale, Clinical Evidence, and Unresolved Questions. [PDF]

Drug Des Devel Ther
Chatzimichail E, Elalfy M, Empeslidis T, Panos GD, Gatzioufas Z.   +4 more
europepmc   +1 more source

Safety signals of perfluorohexyloctane ophthalmic solution in patients with dry eye disease. [PDF]

Front Med (Lausanne)
Sun Z, Liu Y, Que L.
europepmc   +1 more source

Nanocarrier-Mediated Non-Invasive Drug Delivery for Wet Age-Related Macular Degeneration: Advances and Translational Challenges. [PDF]

Pharmaceutics
Wang S, Liu L, Zeng X, Tang C, Chen W, Li X, Lu W.   +6 more
europepmc   +1 more source